0.7310
-0.0160
(-2.14%)
At close: 8:11:34 AM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in SEK | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 1 | 4 | 5 |
| Avg. Estimate | -- | -- | 77.06M | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | 104M | -- |
| Year Ago Sales | -- | 104.24M | -- | 77.06M |
| Sales Growth (year/est) | -- | -100.00% | 0.00% | -100.00% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 6Y4.F | -- | -- | -- | -- |
| S&P 500 | 13.90% | 7.87% | 13.12% | 14.10% |
Related Tickers
HQ1.MU Oruka Therapeutics Inc. R
11.20
+3.70%
8F8.SG SynAct Pharma AB
1.3460
-1.68%
ICY.SG Incyte Corp
68.46
+3.79%
REGN.MX Regeneron Pharmaceuticals, Inc.
13,757.24
+0.80%
605116.SS Aurisco Pharmaceutical Co.,Ltd.
19.75
-2.08%
22UA.DU BioNTech SE
112.70
+4.35%
PH4.F CStone Pharmaceuticals
0.3060
-2.55%
0WA2.IL Cellectis S.A.
1.5200
0.00%
ALGEN.PA genOway Société anonyme
3.5400
+2.31%
REGN34.SA Regeneron Pharmaceuticals, Inc.
64.72
-4.82%